More than 100 economies receive life-saving COVID-19 vaccines from COVAX


More than one hundred economies have received life-saving COVID-19 vaccines from COVAX, the international mechanism for equitable access to COVID-19 vaccines. The milestone comes 42 days after the very first COVAX doses were shipped and provided internationally, to Ghana on 24 February 2021.

COVAX has actually now provided more than 38 million doses throughout six continents, supplied by three makers, AstraZeneca, Pfizer-BioNTech and the Serum Institute of India (SII). Of the over 100 economies reached, 61 are among the 92 lower-income economies getting vaccines moneyed through the Gavi COVAX Advance Market Dedication (AMC).

Regardless of minimized supply accessibility in March and April– the result of vaccine producers scaling and enhancing their production procedures in the early stage of the rollout, in addition to increased demand for COVID-19 vaccines in India– COVAX anticipates to deliver doses to all getting involved economies that have actually requested vaccines in the very first half of the year.

“In under 4 months because the really first mass vaccination outside a clinical setting anywhere in the world, it is greatly satisfying that the roll-out of COVAX doses has currently reached one hundred nations,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.

“COVAX might be on track to provide to all getting involved economies in the very first half of the year yet we still face a daunting difficulty as we seek to end the acute stage of the pandemic: we will just be safe when everybody is safe and our efforts to quickly speed up the volume of doses depend on the ongoing support of governments and vaccine makers. As we continue with the biggest and most rapid worldwide vaccine rollout in history, this is no time at all for complacency.”

“COVAX has offered the world the very best way to make sure the fastest, most fair rollout of safe and reliable vaccines to all at-risk individuals in every nation in the world,” stated Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “If we are going to realize this great opportunity, countries, producers and the worldwide system should come together to prioritize vaccine supply through COVAX. Our collective future, actually, depends on it.”

“This is a substantial milestone in the fight versus COVID-19. Confronted with the fast spread of COVID-19 variants, worldwide access to vaccines is fundamentally crucial to decrease the prevalence of the illness, decrease viral mutation, and speed up the end of the pandemic,” stated Dr Richard Hatchett, CEO of the Union for Epidemic Preparedness Developments (CEPI).

“The extraordinary scientific achievements of the last year must now be matched by an unmatched effort to protect the most susceptible, so the global neighborhood needs to remain strongly concentrated on minimizing the equity gap in COVID-19 vaccine circulation.”

“In simply a month and a half, the aspiration of giving countries access to COVID vaccines is becoming a reality, thanks to the impressive work of our partners in the COVAX Center,” stated Henrietta Fore, UNICEF Executive Director.

“Nevertheless, this is no time to commemorate; it is time to accelerate. With variants emerging all over the world, we need to accelerate international rollout. To do this, we require federal governments, together with other partners, to take necessary steps to increase supply, consisting of by streamlining barriers to intellectual property rights, removing direct and indirect steps that limit exports of COVID-19 vaccines, and donating excess vaccine doses as quickly as possible.”

According to its latest supply forecast, COVAX anticipates to provide at least 2 billion dosages of vaccines in 2021. In order to reach this goal, the COVAX Facility will continue to diversify its portfolio even more, and will reveal brand-new contracts with vaccine manufacturers in due course.

Additionally, in March it was announced that the United States federal government will host the launch event for the 2021 Gavi COVAX AMC Invest Opportunity to catalyze further dedication and support for accelerated access to vaccines for AMC-supported economies. An extra US$ 2 billion is needed in 2021 to fund and protect as much as an overall of 1.8 billion donor-funded dosages of vaccines. COVAX is likewise working to secure additional sourcing of vaccines in the type of dose-sharing from greater earnings nations.

Quotes from donors and partners

President of the European Commission Ursula von der Leyen stated: “As we continue our typical race to accelerate safe and efficient vaccination all over, I want to commend COVAX for having provided first vaccines to 100 countries in every corner of the world, consisting of a few of the most susceptible warn broken nations like Afghanistan and Yemen.

This is a real milestone. Team Europe has highly invested in COVAX and I prompt all partners to support COVAX to make sure no one is left behind”.

Senator the Hon Marise Payne, Minister for Foreign Affairs and Minister for Women, Australia stated: “Australia welcomes the progress made by COVAX in COVID-19 vaccine distribution across the world. One hundred countries now have access to life-saving COVID-19 vaccines through COVAX. We are proud to work with global partners to achieve equitable worldwide access to safe and reliable vaccines.”

Karina Gould, Minister of International Advancement, Canada and co-chair, COVAX AMC Engagement Group stated: “Despite the many obstacles it dealt with, the COVAX Facility has continued to deliver. In simply a matter of weeks, it’s been providing vaccines to 100 countries. This is a turning point we can all take pride in. Now, more than ever, we must continue to work together and support multilateral mechanisms like the COVAX Center and the ACT-Accelerator.”

Jean-Yves le Drian, Minister of Europe and Foreign Affairs, France said: “One hundred nations have now received safe, WHO-approved vaccines versus COVID-19 through the COVAX Center. France invites this important step forward, which shows that multilateralism in worldwide health, in addition to the spirit of uniformity and obligation on which it is based, makes up the most effective response to this pandemic.

However the battle versus the infection is far from over: we must continue to support COVAX and speed up fair access to vaccines in vulnerable countries, in particular through sharing of vaccine doses. This is what France wishes to do, together with its EU and G7 partners.”

Dr Gerd Müller, Federal Minister for Economic Cooperation and Development, Germany stated: “We either beat the pandemic around the world or we will not beat it at all. The only escape of the crisis is a global immunization campaign.

In order to now have the ability to immunize people rapidly, we are utilizing the attempted and checked structures of the worldwide vaccine alliance Gavi. Thanks to the vaccination platform COVAX, the structures are in location to provide vaccines for at least 20 per cent of people in establishing nations and emerging economies over the course of this year.”

Heiko Maas, Minister of Foreign Affairs, Germany stated: “The reality that St.Lucia yesterday ended up being the 100th country to be provided with vaccines via the COVAX platform supported by Germany and the EU, is a turning point on the way out of the pandemic.

This progress offers us hope, for we too will only be safe when everybody around the world is safe. Access to vaccines, medicines and tests should not end up being a geopolitical pawn. Rather, they must be readily available to all nations in a reasonable and transparent manner. That’s why we’re committed to COVAX, to a multilateral approach.”

Colm Brophy TD, Minister of State for Overseas Development and the Diaspora, Ireland stated: “Through our financing to COVAX, Ireland is supporting establishing nations, who many need vaccines and can least manage them, protect their share of worldwide supply.”

Dag-Inge Ulstein, Minister of International Development, Norway, and Co-chair of the ACT-Accelerator Assistance Council stated: “In less than a year, the world has come together to establish and protect fair worldwide access to COVID-19 vaccines. That is a huge success. However the threat of vaccine nationalism is still looming big.

Countries and produces must prioritize international options. It is also crucial that all makers continue to make their vaccines offered and economical to COVAX, so that the global rollout can continue. Countries that have more vaccines than they require ought to share vaccines through COVAX. I likewise anticipate all relevant stakeholders to take action to ensure that the world can produce adequate vaccines, at a price that even the poorest nations can afford.”

People’s health initially’ has actually been the guiding principle, driving all efforts in the battle against the pandemic – both nationally and globally – to make sure that “Nobody is left behind”. We in the kingdom are proud contributors to GAVI and the COVAX center, which has now shipped over 37 million vaccines. This program of solidarity is the treatment to eliminating COVID-19, and our cumulative resilience will enable us to overcome any future pandemic we might deal with.”

H.E. Dr Tawfig AlRabiah, Minister of Health, Saudi Arabia

Foreign, Commonwealth and Development Office Minister Wendy Morton, UK said: “From Nigeria to Nepal, COVAX has now delivered life-saving vaccine dosages to 100 nations and areas which is a big accomplishment and another step towards making all of us safe. The UK has actually played a leading role in attaining fair access to vaccines by offering ₤ 548 million for COVAX early on, which will help to provide more than one billion doses around the world, as well as lobbying international partners to increase their funding.”

United States Secretary of State Antony J. Blinken said: “The United States invites the news that COVAX has provided safe and reliable COVID-19 vaccines to 100 nations. The United States signaled our strong support for COVAX through an initial $2 billion contribution to Gavi. Through unprecedented partnerships among donors, makers, and getting involved nations, COVAX has accomplished amazing milestones in equitably dispersing doses to the international neighborhood in record time.”

Werner Hoyer, President of the European Financial investment Bank stated: “As part of Team Europe the European Financial investment Bank is pleased to offer EUR 400 million for COVAX, representing the EIB’s largest ever assistance for worldwide public health. COVAX has already supplied vaccines to vulnerable groups and front line workers and brought intend to millions more.

COVAX shows the benefit of global cooperation to tackle the shared obstacle of COVID. Congratulations to the COVAX group and global partners in 100 countries around the world. Together we are making sure equitable access to vaccines and together we are directing our efforts towards an international recovery.”

Pascal Soriot, AstraZeneca CEO, said: “Today marks a considerable milestone in the worldwide battle against the pandemic as 100 nations have actually gotten vaccine through COVAX. I am proud that the supply of our vaccine accounts for the huge bulk of dosages being delivered through COVAX in the very first half of this year. Over 37 million dosages of our vaccine have actually been provided to date which are protecting the most vulnerable populations all over the world. Together with our COVAX partners, we continue to work 24/7 to provide on our unwavering commitment to broad, fair and cost effective gain access to.”

Pfizer Chairman and CEO Albert Bourla said: “Congratulations to everyone who has actually worked relentlessly to reach this outstanding turning point. At Pfizer we are driven every day by the belief that science will win. Through cooperation and commitment, COVAX has actually produced an international option that helps to bring development science to everybody, all over. We are proud to interact with the center and all of its partners and remain strongly committed to pursuing the shared vision of fair gain access to for all to end this pandemic.”

Sai D. Prasad, President, Establishing Countries Vaccines Manufacturing Network (DCVMN) said: “COVAX has made history by guaranteeing equitable access for COVID-19 vaccines to all nations regardless of their financial status. The 100th shipment marks a great milestone for COVAX, resulting in boosted deliveries throughout 2021.

We applaud the efforts by all partners in COVAX for this achievement. Developed and establishing nation makers have actually played a crucial role in item advancement and large scale production. In order to satisfy the requirements of all countries, more partnerships between innovators and makers are needed. COVAX’s management in COVID-19 vaccines will guarantee that we leave no one behind.”

Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) & establishing partner of ACT-A stated: “The timeline is really remarkable. It’s an innovation success story with the first WHO vaccine approval on 31 December 2020, less than a year after the infection was very first shared. It’s a production success story with the scaling up from no to one billion dosages being produced by April 2021.

It is a logistics and nation preparedness success story, with 100 countries getting the vaccines and last however by no ways least, it’s a collaboration and uniformity success story, thanks to the commitment from donors and the determined efforts of the partners of COVAX consisting of the establishing and the developed world producers.

COVAX’s collaborations together with political leadership to equitably share surplus vaccines are the best warranties we have that individuals who require the vaccine will get it whenever they live, quickly enough to surpass the infection’ mutations.”


The World Health Organization